Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

22 Sep 2016 Evaluate

Aurobindo Pharma has informed about a Press Release dated September 22, 2016, titled ‘Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the Pepfar market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1802.80
Dr. Reddys Labs. 1355.15
Cipla 1377.50
Lupin 2011.20
Zydus Lifesciences 1235.90
View more..